5 Key Takeaways

• 1

  Influencer promotion of prescription drugs raises public health concerns due to misinformation and limited regulatory oversight.

• 2

  Many influencers present health information beyond their expertise, often overstating benefits and omitting alternative treatments.

• 3

  Regulatory gaps exist, with vague FDA and FTC guidance making enforcement of disclosure rules challenging for influencer content.

• 4

  Parasocial relationships with influencers can reduce audience recognition of persuasive intent, leading to more favorable attitudes toward promoted drugs.

• 5

  Researchers advocate for clearer regulations, standardized disclosures, and improved digital health literacy to mitigate risks associated with influencer promotions.